C4 Therapeutics Inc
NASDAQ:CCCC
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
C4 Therapeutics Inc
NASDAQ:CCCC
|
US |
|
Bausch + Lomb Corp
NYSE:BLCO
|
CA |
|
Microsoft Corp
NASDAQ:MSFT
|
US |
|
Kokuyo Co Ltd
TSE:7984
|
JP |
|
Grifols SA
MAD:GRF
|
ES |
|
Nutrien Ltd
TSX:NTR
|
CA |
|
Gateley (Holdings) PLC
F:5I2
|
UK |
|
Imperial Hotel Ltd
TSE:9708
|
JP |
|
Schlumberger NV
NYSE:SLB
|
US |
|
Intel Corp
NASDAQ:INTC
|
US |
|
Alamtri Resources Indonesia Tbk PT
F:A640
|
ID |
|
Huaneng Lancang River Hydropower Inc
SSE:600025
|
CN |
|
F5 Inc
NASDAQ:FFIV
|
US |
|
Nan Ya Plastics Corp
TWSE:1303
|
TW |
|
S
|
Sibanye Stillwater Ltd
JSE:SSW
|
ZA |
|
Telefonica SA
MAD:TEF
|
ES |
|
B
|
Bank CIMB Niaga Tbk PT
IDX:BNGA
|
ID |
|
Tesco PLC
LSE:TSCO
|
UK |
|
Compagnie Generale des Etablissements Michelin SCA
PAR:ML
|
FR |
|
Ci&T Inc
NYSE:CINT
|
BR |
|
Engie SA
PAR:ENGI
|
FR |
|
Omega Healthcare Investors Inc
NYSE:OHI
|
US |
|
Luk Fook Holdings (International) Ltd
HKEX:590
|
HK |
|
Bright Horizons Family Solutions Inc
NYSE:BFAM
|
US |
Wall St Price Targets
CCCC Price Targets Summary
C4 Therapeutics Inc
According to Wall Street analysts, the average 1-year price target for
CCCC is 11.8 USD with a low forecast of 6.06 USD and a high forecast of 31.5 USD.
Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What you see on other sites is mostly sourced from sell-side analysts.
What is CCCC's stock price target?
Price Target
11.8
USD
According to Wall Street analysts, the average 1-year price target for
CCCC is 11.8 USD with a low forecast of 6.06 USD and a high forecast of 31.5 USD.
What is the Revenue forecast for C4 Therapeutics Inc?
Projected CAGR
46%
Over the last 6 years, the compound annual growth rate for Revenue has been 9%. The projected CAGR for the next 8 years is 46%.